Oncolytics Biotech (ONCY) Operating Income (2011 - 2017)
Oncolytics Biotech's (ONCY) quarterly Operating Income came in at -$3.0 million in Q3 2017, up 9.75% year-on-year from -$2.8 million in Q3 2016, and up 30.41% on a QoQ basis from -$4.4 million in Q2 2017.
Oncolytics Biotech (ONCY) Operating Income (2011 - 2017) Analysis & Trends
Oncolytics Biotech (ONCY) has 7 years of Operating Income data on file, last reported at -$3.0 million in Q3 2017.
- On a quarterly basis, Operating Income rose 9.75% year-over-year to -$3.0 million in Q3 2017; TTM through Sep 2017 was -$15.1 million, a 5486.03% decrease from a year earlier, with the FY2025 full-year figure at -$28.7 million, down 12.46% from the prior year.
- Operating Income for Q3 2017 stood at -$3.0 million, up from -$4.4 million in the prior quarter.
- Over the last five years, Operating Income for ONCY reached as high as $6.2 million in Q3 2013 and fell as low as -$6.7 million in Q1 2013.
- Historically, Operating Income has averaged -$20086.0 across 5 years, with a median of -$209959.5 in 2016.
- Across the five-year window, Operating Income jumped 183.35% in 2014 and tumbled 266.76% in 2017, its largest moves.
- Year by year, Operating Income stood at $6.2 million in 2013, then plunged by 189.48% to -$5.6 million in 2014, then soared by 35.21% to -$3.6 million in 2015, then fell by 13.25% to -$4.1 million in 2016, then advanced by 25.7% to -$3.0 million in 2017.
- Per Business Quant data, the three most recent Operating Income figures were -$3.0 million in Q3 2017, -$4.4 million in Q2 2017, and -$3.6 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -3.04 Mn |
| Jun 30, 2017 | -4.36 Mn |
| Mar 31, 2017 | -3.57 Mn |
| Dec 31, 2016 | -4.09 Mn |
| Sep 30, 2016 | -3.36 Mn |
| Jun 30, 2016 | 2.62 Mn |
| Mar 31, 2016 | 4.09 Mn |
| Dec 31, 2015 | -3.61 Mn |
| Sep 30, 2015 | 2.88 Mn |
| Jun 30, 2015 | 3.89 Mn |
| Mar 31, 2015 | 3.61 Mn |
| Dec 31, 2014 | -5.57 Mn |
| Sep 30, 2014 | 4.68 Mn |
| Jun 30, 2014 | -4.76 Mn |
| Mar 31, 2014 | 5.57 Mn |
| Sep 30, 2013 | 6.22 Mn |
| Jun 30, 2013 | 5.13 Mn |
| Mar 31, 2013 | -6.68 Mn |
| Sep 30, 2012 | 9.30 Mn |
| Jun 30, 2012 | -10.28 Mn |